ScanSource (SCSC) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
18 May, 2026Business transformation and growth strategy
Shifted business model to increase recurring revenue, now representing 33% of gross profit, with a goal to reach 50% in three years.
Expanded gross margin to 13.4% in FY25, up from 10% in FY16, driven by recurring revenue and higher-margin segments.
Embedded a cash flow culture, targeting 80%+ free cash flow conversion of non-GAAP net income annually.
Strategic acquisitions added new capabilities and recurring revenue, supporting ROIC and capital efficiency.
Launched a converged communications business unit to accelerate recurring revenue growth and partner engagement.
Market positioning and competitive advantages
Positioned as a differentiated technology distribution leader with $3B+ net sales and 25,000+ partners.
Delivers complex solutions and advanced expertise, enabling faster partner activation and broader market reach.
Offers flexible go-to-market models, deep specialization, and scalable operational execution for suppliers.
Agency model is asset-light and capital-efficient, with 98% recurring revenue gross profit in this segment.
Value proposition includes technical expertise, custom configuration, and innovative financial solutions for partners and suppliers.
Segment performance and growth drivers
Two segments: Specialty Technology Solutions (76% of gross profit, hardware-centric) and Intelisys & Advisory (24%, agency model, high-margin recurring revenue).
Specialty Technology Solutions focuses on mobility, networking, communications, security, and POS, with mid-single-digit market growth.
Intelisys & Advisory targets connectivity, cloud, security, and wireless, with ~10%+ market growth and strong demand for cloud and AI solutions.
Recurring revenue gross profit grew 22% year-over-year to $134.1M in FY25.
Case studies highlight value creation through converged solutions and high-touch support, driving significant contract wins.
Latest events from ScanSource
- Sales rose 30.1%, but margins and earnings fell; FY27 outlook increased.SCSC
Q1 2027 - Board backs all seven nominees, executive compensation, and Deloitte auditor ratification.SCSC
Proxy filing - Growth, MicroAge integration and longer-term executive incentives headline the proxy.SCSC
Proxy filing - Recurring revenue and strategic M&A drive margin expansion and sustainable growth.SCSC
Investor presentation - Strong Q4 and FY results, with MicroAge acquisition set to drive further margin and sales growth.SCSC
Q4 2026 - Quarterly sales up 8.8% to $766.8M, strong cash flow, margin gains, and new business initiatives.SCSC
Q3 2026 - Recurring revenues and disciplined capital allocation drive margin growth and efficiency.SCSC
47th Annual Raymond James Institutional Investor Conference - Q2 FY26 saw 2.5% sales growth, margin pressure, and reduced full-year guidance.SCSC
Q2 2026 - Sales fell but margins and cash flow improved; acquisitions and hybrid strategy support growth.SCSC
Q4 2024